Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1993 Feb;110(1):127–133. doi: 10.1017/s0950268800050755

Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis.

A E Ades 1, S Parker 1, R Gilbert 1, P A Tookey 1, T Berry 1, M Hjelm 1, A H Wilcox 1, D Cubitt 1, C S Peckham 1
PMCID: PMC2271970  PMID: 8432316

Abstract

A total of 12,902 neonatal samples collected on absorbent paper for routine metabolic screening were tested anonymously for antibodies to toxoplasma. Seroprevalence varied from 19.5% in inner London, to 11.6% in suburban London, and 7.6% in non-metropolitan districts. Much of this variation appeared to be associated with the proportions of livebirths in each district to women born outside the UK. However, additional geographical variation remained and seroprevalence in UK-born women was estimated to be 12.7% in inner London, 7.5% in suburban London, and 5.5% in non-metropolitan areas. These estimates are considerably lower than any previously reported in antenatal sera in the UK. The wide geographical variation highlights a need for further research to determine the relative importance of different routes of transmission.

Full text

PDF
130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect. 1992 Apr;108(2):367–375. doi: 10.1017/s0950268800049839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cubitt W. D., Ades A. E., Peckham C. S. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol. 1992 May;45(5):435–438. doi: 10.1136/jcp.45.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Forsgren M., Gille E., Ljungström I., Nokes D. J. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 1991 Jun 8;337(8754):1413–1414. doi: 10.1016/0140-6736(91)93095-q. [DOI] [PubMed] [Google Scholar]
  4. Parker S. P., Cubitt W. D. Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards. J Clin Pathol. 1992 Oct;45(10):907–909. doi: 10.1136/jcp.45.10.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Peckham C. S., Chin K. S., Coleman J. C., Henderson K., Hurley R., Preece P. M. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet. 1983 Jun 18;1(8338):1352–1355. doi: 10.1016/s0140-6736(83)92138-4. [DOI] [PubMed] [Google Scholar]
  6. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol. 1986 Jan;123(1):174–184. doi: 10.1093/oxfordjournals.aje.a114212. [DOI] [PubMed] [Google Scholar]
  7. Walker J., Nokes D. J., Jennings R. Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect. 1992 Feb;108(1):99–106. doi: 10.1017/s0950268800049542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Williams K. A., Scott J. M., Macfarlane D. E., Williamson J. M., Elias-Jones T. F., Williams H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect. 1981 Sep;3(3):219–229. doi: 10.1016/s0163-4453(81)90773-8. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES